Total planned funding: $12,276,999
Allocations
Countries/Regions
Central Asia Region | $12,276,999 |
Organizational Types
Own Agency | $12,276,999 |
Program Areas
Management and Operations | $9,720,321 |
Prevention | $1,050,748 |
Governance and Systems | $690,527 |
Care | $363,662 |
Testing | $292,410 |
Treatment | $159,331 |
Budget Codes
HVMS: Management and Operations | $9,720,321 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $745,547 |
HBHC: Care: Adult Care and Support | $341,116 |
HVCT: Testing: HIV Testing and Counseling | $292,410 |
HLAB: Laboratory Infrastructure | $247,967 |
HVSI: Strategic Information | $240,486 |
HVOP: Sexual Prevention: Other Sexual Prevention | $204,623 |
OHSS: Health Systems Strengthening | $202,074 |
HTXS: Treatment: Adult Treatment | $141,162 |
HMBL: Biomedical Prevention: Blood Safety | $50,289 |
HMIN: Biomedical Prevention: Injection Safety | $50,289 |
HVTB: Care: TB/HIV | $22,546 |
HTXD: Treatment: ARV Drugs | $18,169 |
Top Partner Programs
USG Aggregated Agencies:
$6,499,999
Countries/Regions
Central Asia Region
2011 | $5,099,999 |
2017 | $1,400,000 |
U.S. Centers for Disease Control and Prevention:
$3,238,500
Countries/Regions
Central Asia Region
2013 | $3,238,500 |
U.S. Agency for International Development:
$2,538,500
Countries/Regions
Central Asia Region
2013 | $2,538,500 |